ESAB delivered a quarter in which the top line and the bottom line told different stories. Core adjusted EPS of $1.30 missed the $1.33 consensus by 3.7% and fell short of the $1.35 Earnings Whisper. Earnings slipped 1.5% from a year ago. Revenue of $824.5 million was a record and beat consensus by 5.6%, rising 13.3% year over year. The gap between those figures is the central tension. ESAB is buying growth through the EWM and Eddyfi acquisitions and improving profitability, but the financing behind those deals is absorbing the operating gains before they reach shareholders. For the second consecutive quarter, management also lowered its full-year earnings outlook.

The operating improvement was real. Core adjusted gross margin rose to 40.2% from 37.7% a year earlier. Core adjusted EBITDA climbed 17% to $156 million, and the 19.8% margin expanded 40 basis points. That reversed a 90-basis-point year-over-year decline in the second quarter. Price contributed 2.5%, up from about 2% last quarter, and management said it remained price-cost neutral despite inflation. Very little of that progress reached per-share earnings:

• Interest expense and other costs jumped to $36.5 million from $23.6 million.
• Acquisition amortization and related charges more than doubled to $39.9 million.
• New common and mandatory convertible preferred shares widened the share base.
• GAAP EPS from continuing operations fell to $0.61 from $1.04.
• Adjusted free cash flow dropped to $60 million from $86 million, weighed down by $38 million in cash interest and a deliberate inventory build.

Organic growth is less impressive than the headline. Core organic sales rose 2.3%, slightly below the 2.5% pace in the second quarter, with volume roughly flat. The Americas grew only about 0.8% organically. US/Canada grew in the high single digits, but the rest of the region fell high single digits because of the Colombia earthquake and an election-related slowdown in Brazil. The Middle East and Africa were still down high single digits, and consumables were roughly flat. There were genuine bright spots:

• North American equipment grew low double digits.
• APAC grew double digits.
• Europe returned to growth.
• Eddyfi grew double digits.
• Its nuclear inspection franchise, which exceeds $80 million in sales, is also expanding at a double-digit rate.

Guidance is where the quarter turned against the bulls. Full-year core adjusted EPS guidance fell to $5.28-$5.33 from $5.40-$5.50. That target was $5.70-$5.90 earlier in the year, and it now sits essentially flat against 2025's $5.27 despite roughly 13% core sales growth. Other targets also came down:

• Organic growth: now 1.6%-2.0%, from 2%-4%.
• Core adjusted EBITDA: now $603-$607 million, from $615-$625 million.
• Free cash flow conversion: about 80%, from roughly 90%.

The reaffirmed 13.1%-13.3% core sales growth rate depends more on acquisitions and currency, with FX now seen adding about 2% versus 0%-1% before. Management cited renewed freight and electronic component inflation and accelerated AI investment as additional pressures. Net leverage of 3.4x improved sequentially but leaves limited room for error.

Management did offer some forward support:

• October orders rose mid-single digits.
• The fourth quarter is guided as the strongest of the year, with about mid-single-digit core growth, margin expansion and better cash flow.
• Additional price increases are planned.
• The Eddyfi cross-selling pipeline expanded to roughly $465 million from about $450 million, with 10-15 late-stage opportunities.
• EWM drew a strong reception from large U.S. customers at Fabtech.

These are credible signs that the acquisition strategy has commercial traction. However, the pipeline has not yet converted into meaningful revenue, and investors have now watched the earnings target fall twice.

The market had already priced in much of this skepticism. Shares entering the report at $76.05 were down 17.3% from the opening price after the August report. They had peaked near $99.89 on that report day, then slid to a 52-week low of $62.74 on October 8. The stock has since rebounded about 21% from that low but still trades roughly 18% below its 200-day moving average. Investor sentiment, already negative, moved further into negative territory, from -0.13 to -0.24. That is a meaningful but not extreme shift. Most Earnings Whispers trend readings remain negative, although momentum has turned positive alongside the rebound from the October low.

The bottom line is that ESAB's operating model is improving, with gross and EBITDA margins expanding and acquired businesses growing. However, organic demand is soft, and the cost of the acquisition financing is consuming that progress at the earnings line. Bears have legitimate ammunition in the missed EPS, weaker cash flow and a twice-lowered profit outlook. Bulls can point to October orders, fourth-quarter guidance and a growing cross-selling pipeline. Until the margin gains and deal synergies begin to lift per-share earnings and cash flow, the story will rest more on management's forecasts than on reported results.